Visual Outcomes After Bilateral Surgical Cataract Phacoemulsification: AcrySof Toric IOL Implantation Compared to Monofocal IOL Implantation

Inclusion Criteria: * are willing and able to understand and sign an informed consent; * are willing and able to attend postoperative examinations per protocol schedule; * are ≥ 21 years of age, of either gender and any race; * have bilateral, age related, cataracts; * have planned cataract removal via phacoemulsification with implantation of an intraocular lens (IOL); * are available to undergo second eye surgery within 6 weeks of the first eye surgery; * are in good ocular health, with the exception of cataracts; * are free of disease(s)/condition(s) listed in the "Precautions" section of the AcrySof Toric and monofocal package inserts: choroidal hemorrhage, chronic severe uveitis, concomitant severe eye disease, extremely shallow anterior chamber, medically uncontrolled glaucoma, microphthalmos, non-age-related cataract, proliferative diabetic retinopathy (severe), severe corneal dystrophy, severe optic nerve atrophy, irregular corneal astigmatism and color vision deficiencies. * have regular corneal astigmatism; * qualify for bilateral AcrySof Toric IOLs on the AcrySof Toric Calculator (www.acrysoftoriccalculator.com) * are able to obtain pupil dilation ≥ 5.0 mm * are able to read and understand one of the following languages: Dutch, French, German Exclusion Criteria: * previous corneal surgery and/or reshaping * abnormality, disease and/or conditions of the cornea (i.e. keratoconus, corneal dystrophy, keratitis, corneal scar, etc.), which would clinically contra-indicate the implantation of a toric intraocular lens * planned multiple procedures during cataract/IOL implantation surgery * planned limbal relaxing incision (LRI), Excimer laser treatment or similar procedure prior to or during the course of the study * an ocular disease and/or condition that may compromise visual acuity levels (i.e. glaucoma, diabetic retinopathy, amblyopia, etc.) * pregnant, lactating or planning pregnancy during course of study. Subjects who become pregnant during the study will not be discontinued; however, data may be excluded from the effectiveness analyses because pregnancy can alter refraction and visual acuity results. Data will be collected on the CRF as observations.